Globus Medical, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US3795772082
USD
88.74
0.99 (1.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
745.34
598.12
657.29
625.71
629.69
606.67
616.53
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
745.34
598.12
657.29
625.71
629.69
606.67
616.53
Raw Material Cost
278.95
224.20
293.35
300.59
289.75
271.16
293.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.78
2.33
1.89
2.58
Selling and Distribution Expenses
300.41
242.74
253.48
240.74
238.12
248.71
244.72
Other Expenses
3.97
3.30
2.08
3.46
3.54
4.28
4.97
Total Expenditure (Excl Depreciation)
619.11
499.91
567.62
576.71
565.57
564.54
590.58
Operating Profit (PBDIT) excl Other Income
126.19999999999999
98.2
89.7
49
64.1
42.1
26
Other Income
112.06
6.66
-35.61
9.71
0.29
-14.66
17.45
Operating Profit (PBDIT)
308.93
170.95
122.29
125.65
128.01
82.72
114.57
Interest
0.00
0.00
0.00
0.78
2.33
1.89
2.58
Exceptional Items
-50.12
-1.21
-29.39
-0.90
-14.50
-34.13
-15.83
Gross Profit (PBDT)
466.39
373.92
363.94
325.11
339.94
335.50
322.93
Depreciation
70.63
66.07
68.23
66.95
63.59
55.26
71.16
Profit Before Tax
188.17
103.67
24.67
57.03
47.58
-8.56
25.00
Tax
-14.67
28.21
-1.84
5.20
15.82
-1.44
9.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
202.85
75.46
26.50
51.84
31.76
-7.12
15.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
202.85
75.46
26.50
51.84
31.76
-7.12
15.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
202.85
75.46
26.50
51.84
31.76
-7.12
15.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
4,295.68
4,088.07
4,177.33
4,069.40
3,976.36
3,922.36
3,997.96
Earnings per share (EPS)
1.49
0.54
0.19
0.38
0.23
-0.05
0.11
Diluted Earnings per share
1.49
0.54
0.19
0.38
0.23
-0.05
0.11
Operating Profit Margin (Excl OI)
16.94%
16.42%
13.64%
7.83%
10.18%
6.94%
4.21%
Gross Profit Margin
34.72%
28.38%
14.13%
19.81%
17.65%
7.7%
15.6%
PAT Margin
27.22%
12.62%
4.03%
8.28%
5.04%
-1.17%
2.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 24.61% vs -9.01% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 168.61% vs 184.91% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 19.84% vs 4.05% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Globus Medical, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
745.34
381.95
363.39
95.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
745.34
381.95
363.39
95.14%
Raw Material Cost
278.95
197.73
81.22
41.08%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
6.78
-6.78
-100.00%
Selling and Distribution Expenses
300.41
113.10
187.31
165.61%
Other Expenses
3.97
1.76
2.21
125.57%
Total Expenditure (Excl Depreciation)
619.11
335.20
283.91
84.70%
Operating Profit (PBDIT) excl Other Income
126.23
46.76
79.47
169.95%
Other Income
112.06
2.20
109.86
4,993.64%
Operating Profit (PBDIT)
308.93
82.76
226.17
273.28%
Interest
0.00
6.78
-6.78
-100.00%
Exceptional Items
-50.12
1.20
-51.32
-4,276.67%
Gross Profit (PBDT)
466.39
184.22
282.17
153.17%
Depreciation
70.63
33.80
36.83
108.96%
Profit Before Tax
188.17
43.38
144.79
333.77%
Tax
-14.67
10.80
-25.47
-235.83%
Provisions and contingencies
0
0
0.00
Profit After Tax
202.85
32.58
170.27
522.62%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
202.85
32.58
170.27
522.62%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
202.85
32.58
170.27
522.62%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
4,295.68
1,488.05
2,807.63
188.68%
Earnings per share (EPS)
1.49
0.54
0.95
175.93%
Diluted Earnings per share
1.49
0.54
0.95
175.93%
Operating Profit Margin (Excl OI)
16.94%
12.24%
0.00
4.70%
Gross Profit Margin
34.72%
20.21%
0.00
14.51%
PAT Margin
27.22%
8.53%
0.00
18.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 74.53 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 24.61% vs -9.01% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 18.36% vs 115.95% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.28 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 168.61% vs 184.91% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 537.74% vs -44.89% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.69 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 19.84% vs 4.05% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 54.19% vs 41.89% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.94%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024